AI-powered search

On-Demand CME Videos

Vitiligo Pearls and the Patient Conversation: Insights for PAs and NPs: An Online Activity

About

Vitiligo Pearls and The Patient Conversation: Insights for PA's and NP's: An Online Activity

This activity is supported by an educational grant from Incyte.

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

June 26, 2024

Expiration Date:

July 7, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Define the current available and emerging therapies for the treatment of vitiligo

  • Describe issues in vitiligo diagnostics and approaches for improving the patient experience

  • Identify approaches for PA/NP cross-collaboration with rest of care team throughout the vitiligo care continuum

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Christine
Christine Davis, (Patient)
Karan
Karan Lal, DO, MS, FAAD

Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ

Francine
Francine Phillips, MPAS, PA-C

Florida Medical Clinic
Land 'O Lakes, FL

E. James
E. James Song, MD, FAAD

Co-Chief Medical Officer and Director of Clinical Research, Frontier Dermatology

Mill Creek, WA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Christine Davis, (Patient)

No relevant financial relationships with any Ineligible Company in the past 24 months.

Karan Lal, DO, MS, FAAD

Advisory Board: Incyte, Galderma, Aphyn Biologics, Verrica, Cerave
Speaker's Bureau or Honoraria: Abbvie, Galderma, Incyte, Boehringer, Verrica

Francine Phillips, MPAS, PA-C

No relevant financial relationships with any Ineligible Company in the past 24 months.

E. James Song, MD, FAAD

Advisory Board: AbbVie, Alpyn, Amgen

Grant/Research Support: SUN Pharma, Dermbiont, AbbVie, BMS, Amgen, Apogee, Moonlake, Janssen, Corevitas, Target, Aslan

Consultant: AbbVie, Alpyn, Amgen

Speakers’ Bureau or Honoraria: AbbVie, Alpyn, Amgen

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved